5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.53▼ | 1.53▼ | 1.54▼ | 1.53▼ | 1.57▼ |
MA10 | 1.53▼ | 1.53▼ | 1.52▼ | 1.56▼ | 2.21▼ |
MA20 | 1.51▲ | 1.53▼ | 1.54▼ | 1.58▼ | 1.32▲ |
MA50 | 1.55▼ | 1.56▼ | 1.57▼ | 2.35▼ | 1.18▲ |
MA100 | 1.57▼ | 1.58▼ | 1.60▼ | 1.38▲ | 3.74▼ |
MA200 | 1.62▼ | 2.01▼ | 2.62▼ | 1.14▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.003▲ | 0.003▲ | 0.032▲ | -0.004▼ |
RSI | 45.874▼ | 44.263▼ | 43.774▼ | 41.532▼ | 50.540▲ |
STOCH | 63.498 | 65.378 | 79.073 | 38.840 | 14.741▼ |
WILL %R | -57.143 | -42.105 | -42.105 | -66.653 | -81.713▼ |
CCI | 5.691 | 12.545 | 3.513 | -85.120 | -20.411 |
MA | $CLDI Price Crossed Below MA(7) | Set Alert |
Monday, September 29, 2025 07:30 AM
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal ...
|
Monday, September 29, 2025 05:00 AM
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 1.53 | 1.56 | 1.51 | 1.52 | 35,434 |
29/09/25 | 1.57 | 1.59 | 1.511 | 1.54 | 121,700 |
26/09/25 | 1.445 | 1.57 | 1.445 | 1.57 | 129,286 |
25/09/25 | 1.52 | 1.53 | 1.44 | 1.45 | 149,053 |
24/09/25 | 1.58 | 1.59 | 1.55 | 1.55 | 71,379 |
23/09/25 | 1.56 | 1.60 | 1.55 | 1.60 | 181,714 |
22/09/25 | 1.55 | 1.61 | 1.55 | 1.61 | 97,941 |
19/09/25 | 1.57 | 1.60 | 1.54 | 1.54 | 140,025 |
18/09/25 | 1.61 | 1.61 | 1.57 | 1.58 | 187,888 |
17/09/25 | 1.57 | 1.62 | 1.57 | 1.62 | 132,129 |
|
|
||||
|
|
||||
|
|